SEC Won't Let Steve Be

What happened between Apple’s January 5 disclosure of Steve Jobs’s “hormonal imbalance” and the company’s January 14 announcement that the CEO would be taking a six-month leave of absence? That’s the focus of an ongoing Securities and Exchange Commission probe into Steve Jobs’s health, an investigation that seems to, well, be going nowhere.
stevewtf

SEC Won’t Let Steve Be

What happened between Apple’s January 5 disclosure of Steve Jobs’s “hormonal imbalance” and the company’s January 14 announcement that the CEO would be taking a six-month leave of absence? That’s the focus of an ongoing Securities and Exchange Commission probe into Steve Jobs’s health, an investigation that seems to, well, be going nowhere.
stevewtf

Report: Steve Jobs Is Recovering From Liver Transplant, Still Coming Back to Apple

The Steve Jobs health story takes yet another twist, this time a happier one: The Wall Street Journal is reporting that the Apple CEO underwent a liver transplant earlier this spring, and is recovering from the operation. Jobs, who stepped away from day-to-day management of his company in January, is still expected to return to work later this month.
411px-steve_jobs

Maybe the Feds Can Diagnose What Ails Apple and Steve Jobs (and Whether It Matters or Not)

Early this morning, Bloomberg reported that regulators are looking into Apple’s disclosures about the health–or lack thereof–of its iconic CEO Steve Jobs. And while BoomTown has railed against the creepy obsession the media have had with Jobs’s health and the publishing of rumors and innuendos about it as fact without a whole lot of reporting, I hope it is true. It is also entirely appropriate that the government agency charged with keeping an eye on public companies does investigate–at the very least, to get the story right.